Top Markets
#1 Bitway Bitway +55.02%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +41.19%
#3 Starpower Starpower +37.49%
#4 Pons Pons +34.50%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.80%
#6 aelf aelf +22.66%
#7 SkyAI SkyAI +19.87%
#8 Ocean Protocol Ocean Protocol +18.26%
#9 OpenEden OpenEden +18.13%
#10 Mubarak Mubarak +15.20%
Coin of the day
Bitway Bitway
Settings
Language
ENGLISH
Currency
USD
Theme
SynCore Biotechnology Co.,Ltd SynCore Biotechnology Co.,Ltd

SynCore Biotechnology Co.,Ltd

4192
Rank in Stocks #29318
SynCore Biotechnology Co.,Ltd, a Taiwan-based enterprise, specializes in the... SynCore Biotechnology Co.,Ltd, a Taiwan-based enterprise, specializes in the development and commercialization of biotechnology services, alongside offering expertise in food advisory and medicine inspection. The company's robust pipeline includes several promising drug candidates. Among its novel chemical entities (NCEs), SB01 is an injectable anti-cancer compound currently undergoing Phase II clinical trials for head and neck cancer. Another anti-cancer NCE, SB02, is in preclinical development, targeting stomach cancer. Beyond novel compounds, SynCore also markets established pharmaceutical solutions. This includes SB03-Veregen, an ointment prescribed for external genital and perianal warts. Its portfolio further extends to SB04, a conventional medication for age-related macular degeneration, presently in Phase II clinical studies. Additionally, SynCore is advancing SB05-EndoTAG, an established drug undergoing Phase III clinical trials for the treatment of both pancreatic cancer and triple-negative breast cancer. In a related venture, the company distributes epiCam brand cameras, which are designed for recording the progression of ophthalmic diseases. SynCore maintains strategic collaborations with notable entities such as Medigene AG, MacuCLEAR Inc., Sinphar Pharmaceutical Co., Ltd., and The National Health Research Institutes. Founded in 2008, SynCore Biotechnology Co.,Ltd is headquartered in Yilan City, Taiwan, and operates as a subsidiary of Sinphar Pharmaceutical Co., Ltd.
Share Price
$0.62008105
Last synced: 2026-08-18
Market Cap
$21.81M
Change (1 day)
0.26%
Change (1 year)
-31.95%
Country
TW
Trade SynCore Biotechnology Co.,Ltd (4192)

Category

Healthcare
Stock split history for SynCore Biotechnology Co.,Ltd (4192)
SynCore Biotechnology Co.,Ltd stock (symbol: 4192) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 19, 2026.
One 4192 share bought prior to Aug 19, 2026 would equal to 0 4192 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH